NCT02765867View on ClinicalTrials.gov

Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Opioid Use Disorder
Interventions
DRUG

RBP-6000

A single injection of RBP-6000 containing a low dose of buprenorphine in the Atrigel delivery system

Trial Locations (1)

33301

Scientific Clinical Research, Fort Lauderdale

Sponsors

Lead Sponsor

Indivior Inc.
All Listed Sponsors
lead

Indivior Inc.

INDUSTRY

NCT02765867 - Single-dose, Study of RBP-6000 in Opioid Dependent Individuals | Biotech Hunter | Biotech Hunter